In the zebrafish PD model, MPTP treatment might alter the intracellular environment, including increased oxidative stress and mitochondrial dysfunction, which caused a decrease in the expression of 4E-BP1 protein. This evidence concerns the gene EIF4EBP1 and Parkinson disease.